TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AQST

Aquestive Therapeutics Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.70$ -2.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Aquestive Therapeutics Inc (AQST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 132 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AQST
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
59 57 130 118 110 101 102 94 164 160 141 132
42 41 113 104 97 88 89 82 152 149 130 118
25 24 95 90 78 72 69 61 129 121 111 98
25 24 95 90 78 72 69 61 129 121 111 98
8.6 8.5 8.3 6.0 9.7 7.3 10 12 12 18 6.9 9.3
7.1 6.8 7.7 7.0 7.0 6.0 7.2 8.1 7.9 6.2 8.1 7.4
1.3 1.3 1.2 – – – – – – – – –
162 164 166 153 155 162 163 166 168 194 175 189
24 18 18 14 15 19 18 23 26 48 32 16
5.0 0.4 0.4 0.5 0.5 0.5 0.6 3.7 8.5 12 15 0.8
10.0 8.9 11 5.7 7.6 10 12 12 11 30 12 9.0
35 28 29 30 31 33 34 32 30 28 25 51
-103 -106 -36 -35 -45 -60 -61 -73 -4.1 -34 -34 -57
-311 -319 -332 -335 -346 -363 -386 -400 -415 -447 -455 -478
65 69 74 91 91 91 95 99 111 122 123 125

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?